Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Sana Biotech stock soars after outspoken stock promoter Eric Jackson names it as his latest potential "100-bagger."
Famed short seller Jim Chanos slams IREN's growth story, citing "Hopium," questionable accounting, and a 9-year GPU...
Eric Jackson is long Hut 8 (HUT), citing its pivot from a miner to an undervalued AI infrastructure play with 100x potential.
Cantor Fitzgerald analyst Brett Knoblauch maintains IREN (NASDAQ:IREN) with a Overweight and raises the price target from $4...
BTIG analyst Gregory Lewis maintains IREN (NASDAQ:IREN) with a Buy and raises the price target from $32 to $75.
Discover why expert Shay Boloor calls IREN & Nebius top 'AI Utility' picks for the next industrial wave of the AI t...
